About: Komentář ke studii ADVANCE (Action in diabetes and vascular disease: preterAx and diamicroN-MR controlled evaluation)     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Analysis of the ADVANCE study, where indication of 1 tbl Prestarium Combi in patients with type 2 diabetes reduced the incidence of micro- and macro-vascular complications significancy. (en)
  • Zamyšlení nad studií ADVANCE, kdy přidání 1 tbl Prestarium Combi nemocným s diabetem 2. typu významně snížila výskyt mikro- a makro-vaskulárních komplikací.
  • Zamyšlení nad studií ADVANCE, kdy přidání 1 tbl Prestarium Combi nemocným s diabetem 2. typu významně snížila výskyt mikro- a makro-vaskulárních komplikací. (cs)
Title
  • Komentář ke studii ADVANCE (Action in diabetes and vascular disease: preterAx and diamicroN-MR controlled evaluation)
  • Comment to the ADVANCE (Action in diabetes and vascular disease: preterAx and diamicroN-MR controlled evaluation) study (en)
  • Komentář ke studii ADVANCE (Action in diabetes and vascular disease: preterAx and diamicroN-MR controlled evaluation) (cs)
skos:prefLabel
  • Komentář ke studii ADVANCE (Action in diabetes and vascular disease: preterAx and diamicroN-MR controlled evaluation)
  • Comment to the ADVANCE (Action in diabetes and vascular disease: preterAx and diamicroN-MR controlled evaluation) study (en)
  • Komentář ke studii ADVANCE (Action in diabetes and vascular disease: preterAx and diamicroN-MR controlled evaluation) (cs)
skos:notation
  • RIV/00216208:11140/07:00000358!RIV08-MSM-11140___
http://linked.open.../vavai/riv/strany
  • 442;443
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • V
http://linked.open...iv/cisloPeriodika
  • 5
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 429336
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11140/07:00000358
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Comment; ADVANCE; Action; diabetes; vascular; disease; preterAx; diamicroN-MR; controlled; evaluation; study (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • CZ - Česká republika
http://linked.open...ontrolniKodProRIV
  • [6F83BA88CFA2]
http://linked.open...i/riv/nazevZdroje
  • Farmakoterapie
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 3
http://linked.open...iv/tvurceVysledku
  • Rosolová, Hana
issn
  • 1801-1209
number of pages
http://localhost/t...ganizacniJednotka
  • 11140
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 112 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software